Calcimedica announces upcoming plenary presentation at the 30th international aki & crrt conference

La jolla, calif. , feb. 19, 2025 /prnewswire/ -- calcimedica inc. ("calcimedica" or the "company") (nasdaq: calc), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (crac) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced a plenary presentation at the 30th international acute kidney injury and continuous renal replacement therapy conference (aki & crrt) being held march 3-6, 2025 in san diego, ca.
CALC Ratings Summary
CALC Quant Ranking